Company: NCEL
Filing Date: 2025-02-05
Form Type: F-3
Source: 0001213900-25-010223
Chunk: 2

Company: NewcelX Ltd.
Filing Date: 2025-02-05
Form: F-3
Chunk 2
---
, or the December SPA, (ii) 75,000 Common Shares issued pursuant to an October 2024 securities purchase agreement, or the October Debt SPA, and (iii) 408,871 Common Shares issuable upon the conversion of certain of the Company’s preferred participation certificates, par value CHF 0.03 per certificate, or the PPCs, pursuant to the October Debt SPA.

The Selling Shareholder is identified in the table commencing on page 76. No Common Shares are being registered hereunder for sale by us. We will not receive any proceeds from the sale of the Common Shares by the Selling Shareholder. All net proceeds from the sale of the Common Shares covered by this prospectus will go to the Selling Shareholder. The Selling Shareholder may sell all or a portion of the Common Shares from time to time in market transactions through any market on which our Common Shares are then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined by the then prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal or by a combination of such methods of sale. See “Plan of Distribution.”

Our Common Shares trade on
the Nasdaq Capital Market, or Nasdaq, under the symbol “NLSP.” On February 3, 2025, the last reported sale price of our Common
Shares on Nasdaq was $2.17 per share.

We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and are subject to reduced public company reporting requirements.

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 29 of this prospectus.

Neither the Securities and Exchange Commission, or the SEC, nor any state or other foreign securities commission has approved nor disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025.

TABLE OF CONTENTS</div>

|                                           |     | Page |
| ABOUT                                     
 THIS PROSPECTUS                           |     |  iii |
| PROSPECTUS                                
 SUMMARY                                   |     |    1 |
| KADIMASTEM                                
 BUSINESS                                  |     |    7 |
| THE                                       
 OFFERING                                  |     |   28 |
| RISK                                      
 FACTORS                                   |     |